Patent details

Basic Information

Publication number:

93320

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP101749851

Legal Status:

Invalid

Application number:

93320

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/09/538-001-006 - Afinitor - everolimus

Marketing Authorization Type:

Marketing Authorization Date:

05/08/2009

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

23/11/2016

First Marketing Authorization date:

05/08/2009

Grant date:

30/01/2017

Activation date:

Publication date:

30/01/2017

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

05/08/2024

SPC Extension Expiration:

05/08/2024

Rejection date:

Withdrawal date:

Owner

From:

10/06/2020

 

 

Name:

NOVARTIS PHARMA AG

Address:

Forum 1 Novartis Campus, 4056, Basel, Switzerland (CH)

History of Owners

From:

13/03/2019

To:

10/06/2020

Name:

NOVARTIS INTERNATIONAL PHARMACEUTICAL AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Name:

NOVARTIS PHARMA AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

From:

23/11/2016

To:

13/03/2019

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

23/11/2016

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Lane Heidi

Address:

Switzerland (CH)

2

Name:

Wood Jeanette Marjorie

Address:

Switzerland (CH)

3

Name:

O'Reilly Terence

Address:

Switzerland (CH)

Licencee

Name:

N.V. Novartis Pharma S.A.

From:

27/03/2019

Address:

Medialaan 40, 1800, Vilvoorde, Belgium (BE)

To:

Publication

Bulletin

1

Bulletin Heading:

SPC2

Bulletin edition number:

2017/02

Publication date:

22/06/2017

Description:

Section D : Granted supplementary protection certificates – I2 publication

2

Bulletin Heading:

CO

Bulletin edition number:

2019/05

Publication date:

11/04/2019

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

3

Bulletin Heading:

MED

Bulletin edition number:

2019/06

Publication date:

06/05/2019

Description:

Section K : Modifications and recordals into the register

4

Bulletin Heading:

CO

Bulletin edition number:

2020/08

Publication date:

13/07/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

5

Bulletin Heading:

VRV

Bulletin edition number:

2021/13

Publication date:

02/12/2021

Description:

Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000121A

Date Registered:

13/03/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

1

Name:

NOVARTIS PHARMA AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

2

Name:

NOVARTIS INTERNATIONAL PHARMACEUTICAL AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Removed Pledgee

Name:

Address:

Licence

Change Kind/ Decision Type:

New licence registration

Deed Number:

RC20190000139G

Date Registered:

27/03/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Not Exclusive

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Luxembourg (LU)

Updated Licence Number:

Terminated Licence Number:

Added Licencee(s)

Name:

N.V. Novartis Pharma S.A.

Address:

Medialaan 40, 1800, Vilvoorde, Belgium (BE)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20200000167A

Date Registered:

10/06/2020

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

NOVARTIS PHARMA AG

Address:

Forum 1 Novartis Campus, 4056, Basel, Switzerland (CH)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
10/03/2017	Publication	1
10/06/2020	Request For Change	12
21/03/2019	Outgoing Correspondence	2
27/03/2019	Request For Change	6
10/03/2017	Certificate	1
13/03/2019	Request For Change	6
01/04/2019	Outgoing Correspondence	1